Guangdong Marubi Biotechnology Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 1,137.293 million compared to CNY 1,211.590 million a year ago. Operating income was CNY 413.853 million compared to CNY 427.281 million a year ago. Net income was CNY 337.964 million compared to CNY 359.094 million a year ago. Basic earnings per share from continuing operations was CNY 0.84 compared to CNY 0.97 a year ago.